Novartis Oncology | Cancer Resources For Patients & Caregivers

Local websites

Venezuela

Businesses

Other websites

General contact

Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

More information

Investors

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

+41 61 324 79 44
investor.relations@novartis.com

More information

Media

Global Oncology Media Relations
Denise Brashear
Novartis Oncology Global Public Relations

+1 862 778 7336
Denise.Brashear@novartis.com

Novartis Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999
eric.althoff@novartis.com

More information

pane 4 content

This site is not intended for U.S. residents.

For Patients & Caregivers

Bringing hope

to patients and their families

Open

For Patients & Caregivers

Novartis Oncology is committed to developing innovative medicines and improving access to them through patient assistance and cancer resource programs.

Patient Resources

Learn about oncology-related resources that are of interest to patients. Learn more

Bone metastasis

Learn about bone metastasis and Novartis Oncology’s commitment to research & development for patients living with bone metastases. »

Breast cancer

Learn about breast cancer and the targeted therapies that Novartis Oncology is exploring for estrogen receptor-positive breast cancer cells and the PI3K/AKT/mTOR pathway. »

Chronic myeloid leukemia

Learn about chronic myeloid leukemia (CML) and what Novartis Oncology is doing to help improve long-term outcomes for patients living with CML. »

Endocrine diseases

Learn about endocrine diseases and how Novartis Oncology is focusing its research on rare conditions like acromegaly and Cushing’s disease. »

Gastrointestinal stromal tumors

Learn about gastrointestinal stromal tumors (GIST) and Novartis Oncology’s commitment to discovering therapies for patients living with GIST. »

Iron overload

Learn about iron overload and what Novartis Oncology is doing to lower liver iron concentration and serum ferritin of patients living with transfusion-dependent anemias. »

Myelofibrosis

Learn about Novartis Oncology’s targeting strategy for the JAK-STAT signaling pathway to treat patients with myeloproliferative neoplasms such as myelofibrosis. »

Neuroendocrine tumors

Learn about neuroendocrine tumors (NET) and Novartis Oncology’s exploration of neuroendocrine tumors of pancreatic origin, or pNET. »

Renal cell carcinoma

Learn about renal cell carcinoma and Novartis Oncology’s commitment to discovering therapies for patients living with kidney cancer. »

SEGA tumors

Learn about Novartis Oncology’s commitment to discovering therapies for patients living with subependymal giant cell astrocytoma (SEGA) tumors and tuberous sclerosis complex (TSC). »

Patient assistance programs

Learn about established patient assistance programs that help patients in need, in both developing and developed countries. »

Patient advocacy groups

Learn how advocacy groups help us better understand patient needs and barriers to treatment success. »

Additional resources

Learn about oncology-related resources that are of interest to patients. »